Effect of Sulodexide in Early Diabetic Nephropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

1,056

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Diabetic Nephropathy
Interventions
DRUG

Sulodexide

100 mg sulodexide gelcaps

DRUG

Placebo

0 mg gelcap

Trial Locations (3)

3168

The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center, Melbourne

60612

The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center, Chicago

9713 AV

The Collaborative Study Group, Clinical Coordinating Center for European Clinics, University of Groningen, Groningen

Sponsors
All Listed Sponsors
collaborator

Collaborative Study Group (CSG)

NETWORK

lead

Keryx Biopharmaceuticals

INDUSTRY

NCT00130208 - Effect of Sulodexide in Early Diabetic Nephropathy | Biotech Hunter | Biotech Hunter